Cor Vasa 2006, 48(2):72-74 | DOI: 10.33678/cor.2006.025

Další informace o studii FIELD (Fenofibrate Intervention and Event Lowering in Diabetes]

Jiří Widimský

Published: February 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský J. Další informace o studii FIELD (Fenofibrate Intervention and Event Lowering in Diabetes]. Cor Vasa. 2006;48(2):72-74. doi: 10.33678/cor.2006.025.
Download citation

References

  1. The FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849-61. Go to original source... Go to PubMed...
  2. Colhoun H. After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes? Lancet 2005; 366:1829-31. Go to original source... Go to PubMed...
  3. Colhoun HM, Betteridge DJ, Durrington PN, for the CARDS Group. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685-96. Go to original source... Go to PubMed...
  4. Collins R, Armitage J, Parish S. for the Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-16. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.